Copyright
©The Author(s) 2019.
World J Cardiol. May 26, 2019; 11(5): 137-148
Published online May 26, 2019. doi: 10.4330/wjc.v11.i5.137
Published online May 26, 2019. doi: 10.4330/wjc.v11.i5.137
Outcomes | ACS + no gout(n = 3039546) | ACS + gout(n = 105198) | P value |
Revascularization | |||
Thrombolysis | 56694 (1.9) | 1408 (1.3) | < 0.001a |
PCI | 1369759 (45.1) | 38301 (36.4) | < 0.001a |
CABG | 245983 (8.1) | 9657 (9.2) | < 0.001a |
All-cause in-hospital mortality | 151213 (5.0) | 4539 (4.3) | < 0.001a |
Disposition | < 0.001a | ||
Routine | 1878724 (61.8) | 59605 (56.7) | |
Transfer to short-term hospital | 290145 (9.6) | 10506 (10.0) | |
Other transfers (SNF, ICF, other) | 367183 (12.1) | 15586 (14.8) | |
Home Health Care | 318501 (10.5) | 14208 (13.5) | |
Against Medical Advice | 30531 (1.0) | 681 (0.6) | |
Length of stay (d) mean (± SD) | 4.5 (± 5.2) | 5.1 (± 5.0) | < 0.001a |
Hospital charges ($) mean (± SD) | 71312.73 (± 85186.10) | 72328.21 (± 86223.92) | < 0.001a |
- Citation: Desai R, Parekh T, Goyal H, Fong HK, Zalavadia D, Damarlapally N, Doshi R, Savani S, Kumar G, Sachdeva R. Impact of gout on in-hospital outcomes of acute coronary syndrome-related hospitalizations and revascularizations: Insights from the national inpatient sample. World J Cardiol 2019; 11(5): 137-148
- URL: https://www.wjgnet.com/1949-8462/full/v11/i5/137.htm
- DOI: https://dx.doi.org/10.4330/wjc.v11.i5.137